Poster (download)
458
Julia F. Semenova1, Maksim V. Dashkin2, Olga N. Fazullina3
1Laboratory of Endocrinology Research Institute of Clinical and Experimental Lymphology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences(RICEL – Branch of IC&G SB RAS) Novosibirsk, Russia, ekmxtyjr@yandex.ru
2Research Institute of Clinical and Experimental Lymphology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences (RICEL – Branch of IC&G SB RAS) Novosibirsk, Russia, mdashkin@invitro.ru
3Laboratory of Endocrinology Research Institute of Clinical and Experimental Lymphology – Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences(RICEL – Branch of IC&G SB RAS) Novosibirsk, Russia, fazullina@ngs.ru
Background and aim: Continuous glucose monitoring (CGM) provides an excellent opportunity for in-depth assessment of glycemic control and glucose variability (GV) in diabetic subjects. The aim of our study was to determine the clinical and metabolic parameters associated with non-targeted time in range (TIR) increased GV in patients with type 2 diabetes (T2D) treated with insulin.В Materials and Methods: One hundred and thirty six insulin-treated patients with T2D were included. Real-time or blinded CGM was performed using Medtronic CGM devices. The TIR and Mean Amplitude of Glucose Excursion (MAGE) were estimated. The advance glycation end-products (AGEs) levels were measured in blood serum by ELISA.В Results: Patients with non-targeted TIR (>70%) had higher glycated hemoglobin HbA1c, triglycerides and proteinuria as compared to those with targeted TIR. Urinary albumin-to-creatinine ratio tended to be higher in patients with non-targeted TIR also. Patients with higher MAGE (>4.5 mmol/l) demonstrated lower levels of triglycerides and uric acid and increased AGEs levels as compared to those with MAGE <4.5 mmol/l.В Conclusions: In T2D subjects, non-targeted TIR is associated with hypertriglyceridemia and proteinuria, meantime, increased MAGE is related to lower serum levels of triglycerides and uric acid and higher levels of AGEs.
Is continuous glucose monitoring a sought-after procedure for surgical patients preparing for amputation of extremity?
Thank you for your report.
Thanks for your question. A differentiated approach to the conduct of CGM is required. If the patient is not compensated, there is a suspicion of episodes of latent hypoglycemia, the conduct of CGM is necessary in this case.
… [Trackback]
[…] Read More on to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] There you will find 90479 additional Information to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
Clinical and metabolic parameters associated with time in ranges and glucose variability in patients with type 2 diabetes treated with insulin
http://www.vaticanhistory.de/wordpress/?p=11782
… [Trackback]
[…] There you will find 9093 more Info to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Read More here to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Read More here to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Info to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Info to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Info on that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Read More on on that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Find More to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Information to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Information to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Read More Info here on that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Read More on that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Find More to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] Information to that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]
… [Trackback]
[…] There you will find 67007 more Info on that Topic: bgrssb.icgbio.ru/2020/2020/06/29/clinical-and-metabolic-parameters-associated-with-time-in-ranges-and-glucose-variability-in-patients-with-type-2-diabetes-treated-with-insulin/ […]